ACAD
27.08
-1.17
-4.14%
AEMD
4.8
+0.15
+3.23%
APRI
1.24
-0.05
-3.88%
ARNA
1.4
-0.08
-5.41%
ATEC
4.85
-0.07
-1.42%
CNAT
1.96
+0.04
+2.08%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.55
0.00
0.00%
DXCM
63.04
-2.44
-3.73%
GNMK
10.98
-0.26
-2.31%
HALO
11.31
-0.57
-4.80%
ILMN
122.02
-4.38
-3.47%
INNV
0.263
+0.003
+1.0769%
INO
6.97
-0.34
-4.65%
ISCO
1.31
+0.11
+9.17%
ISIS
0
0.00
0.00%
LGND
102.59
-3.28
-3.10%
LPTN
2.62
-0.06
-2.2351%
MBVX
4.06
+0.03
+0.74%
MEIP
1.54
-0.03
-1.91%
MNOV
7.58
-0.03
-0.39%
MRTX
5.35
+0.25
+4.90%
MSTX
0.083
+0.001
+1.7073%
NBIX
42.94
-2.09
-4.64%
NUVA
66.83
+0.2
+0.30%
ONCS
1.348
-0.002
-0.1778%
ONVO
3.09
-0.07
-2.22%
OREX
1.84
-0.1
-5.15%
OTIC
16.2
0.00
0.00%
QDEL
22.2
-0.03
-0.13%
RCPT
0
0.00
0.00%
RGLS
2.65
0.00
0.00%
RMD
60.34
+0.56
+0.94%
SCIE
0.002
0.00
-5.2632%
SPHS
2.74
-0.03
-1.08%
SRNE
5.2
-0.2
-3.70%
TROV
2.3
-0.2
-8.00%
VICL
2.34
+0.02
+0.86%
ZGNX
13
-0.25
-1.89%
ACAD
27.08
-1.17
-4.14%
AEMD
4.8
+0.15
+3.23%
APRI
1.24
-0.05
-3.88%
ARNA
1.4
-0.08
-5.41%
ATEC
4.85
-0.07
-1.42%
CNAT
1.96
+0.04
+2.08%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.55
0.00
0.00%
DXCM
63.04
-2.44
-3.73%
GNMK
10.98
-0.26
-2.31%
HALO
11.31
-0.57
-4.80%
ILMN
122.02
-4.38
-3.47%
INNV
0.263
+0.003
+1.0769%
INO
6.97
-0.34
-4.65%
ISCO
1.31
+0.11
+9.17%
ISIS
0
0.00
0.00%
LGND
102.59
-3.28
-3.10%
LPTN
2.62
-0.06
-2.2351%
MBVX
4.06
+0.03
+0.74%
MEIP
1.54
-0.03
-1.91%
MNOV
7.58
-0.03
-0.39%
MRTX
5.35
+0.25
+4.90%
MSTX
0.083
+0.001
+1.7073%
NBIX
42.94
-2.09
-4.64%
NUVA
66.83
+0.2
+0.30%
ONCS
1.348
-0.002
-0.1778%
ONVO
3.09
-0.07
-2.22%
OREX
1.84
-0.1
-5.15%
OTIC
16.2
0.00
0.00%
QDEL
22.2
-0.03
-0.13%
RCPT
0
0.00
0.00%
RGLS
2.65
0.00
0.00%
RMD
60.34
+0.56
+0.94%
SCIE
0.002
0.00
-5.2632%
SPHS
2.74
-0.03
-1.08%
SRNE
5.2
-0.2
-3.70%
TROV
2.3
-0.2
-8.00%
VICL
2.34
+0.02
+0.86%
ZGNX
13
-0.25
-1.89%
Home » SDBN Blog

Bioethics in Drug Development: BIO2014

Submitted by on June 24, 2014 – 6:52 am

Consider a case where a patient has a disease with high mortality and no effective treatment available. A new experimental drug is now being tested in a clinical trial. However, this is a randomized clinical trial, which means that it will have a treatment group and a placebo group (that does not get the actual drug).

via Bioethics in Drug Development: BIO2014.

Tags:

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

Please prove you\'re human, solve this: *
Time limit is exhausted. Please reload CAPTCHA.